Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fulton Bank N.A. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 50.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 28,921 shares of the biopharmaceutical company’s stock after selling 29,866 shares during the period. Fulton Bank N.A.’s holdings in Gilead […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 15,280,000 shares, a decrease of 15.0% from the May 15th total of 17,980,000 shares. Based on an average daily trading volume, of 5,570,000 shares, the days-to-cover ratio […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) insider Merdad Parsey sold 1,485 shares of the business’s stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $76.90, for a total transaction of $114,196.50. Following the sale, the insider now directly owns 29,402 shares in the company, valued at […]
Cognios Beta Neutral Large Cap Fund LP purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 14,135 shares of the biopharmaceutical company’s stock, valued at approximately $1,213,000. Gilead Sciences accounts […]
AlphaCore Capital LLC decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,849 shares of the biopharmaceutical company’s stock after selling 160 shares during the quarter. AlphaCore […]